Webinar Date/Time: Thursday, October 3, 2024 at 2pm EDT|11am PDT|7pm BST|8pm CEST
In this webinar, a panel of IQVIA experts will discuss the evolution of commercial pharma leaders’ strategies for enhancing health care provider interactions, shifting from traditional face-to-face promotion to integrated omnichannel approaches for a more personalized customer experience. Additionally, the panel will address the need to adapt to physicians’ preferences in today’s market, ensuring effective engagement and optimized business outcomes.
Register Free: https://www.pharmexec.com/pe_w/digital-engagement
Event Overview:
Commercial pharma leaders aim to enhance their strategies for health care provider (HCP) interactions and provide a unique customer experience beyond the product itself. As the HCP engagement model evolves to align with physicians’ preferences, we are witnessing a swift shift from traditional face-to-face (F2F) promotion to more truly integrated, omnichannel approaches, which can enable greater personalization. In today’s dynamic market, it is essential to consider various factors to determine the most effective ways to engage with HCPs and optimize your business outcomes.
Three key take-aways
Speakers
Matthew Smith
Senior Principal, New Commercial Models and Digital Engagement
IQVIA
Matthew Smith has more than 20 years of combined consulting and industry experience and has a passion for helping biopharma organizations put the customer at the heart of their operations. Currently, Smith leads IQVIA’s New Commercial Models and Digital Engagement Center of Excellence, where he focuses on helping companies to take a data-driven approach while harnessing digital channels and technologies to drive customer-centric change. Prior to joining IQVIA, Smith has held various digital and strategy leadership positions with Pfizer, Allergan, Capgemini, and EY. Smith has also worked across a variety of sectors outside of biopharma, and can draw upon experiences in financial services, energy and consumer goods.
Ruoxin Li, PhD, MBA
Senior Director, Advanced Analytics, SFE
IQVIA
Ruoxin Li, PhD, MBA, is a leader in analytics, spearheading methodologies and techniques to deliver insights that drive data-driven decision-making. He leads multiple analytical endeavors in identifying opportunities, driving business growth, and optimizing operations. He is a published innovator in artificial intelligence/machine learning, business analytics and data platforms.
Paige Desmarais, BS
Principal, Sales Force Effectiveness
IQVIA
Paige Desmarais, BS, has over 14 years of experience in sales operations; reporting and analytics; database design and management; process management; and systems development within the life sciences industry. Desmarais has in-depth knowledge in the areas of sales force size and structure; call planning and targeting; CRM; sales force alignments; and incentive compensation.
Register Free: https://www.pharmexec.com/pe_w/digital-engagement
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.